Sign in

CIK 0001768446

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Climb Bio, Inc.

Sign in to watch
Ticker
CLYM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
832273741
Phone
+1 866-857-2596
Business address
20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
Former names
Eliem Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,366,820
in 1 filing, $1.4M under 10b5-1 plans

Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thomas Stephen Basil −$1.4M Director sold 18% of stake
Date Insider Transaction Shares Price Value Owned after
2025-06-20 Pimblett Emily SVP, Finance & CAO Sale 10b5-1 −1,242 $1.24 $2K 18,888
2025-06-18 Pimblett Emily SVP, Finance & CAO Option exercise 10b5-1 +5,000 20,130
2025-06-18 Pimblett Emily SVP, Finance & CAO Option exercise · Restricted Stock Units 10b5-1 −5,000 15,000
2025-03-20 Pimblett Emily SVP, Finance & CAO Sale 10b5-1 −1,199 $1.31 $2K 15,130
2025-03-18 Pimblett Emily SVP, Finance & CAO Option exercise 10b5-1 +5,000 16,329
2025-03-18 Pimblett Emily SVP, Finance & CAO Option exercise · Restricted Stock Units 10b5-1 −5,000 20,000
2025-01-13 Pimblett Emily SVP, Finance and CAO Grant or award · Stock Option (Right to Buy) +100,000 100,000
2024-12-19 Pimblett Emily CHIEF ACCOUNTING OFFICER Sale 10b5-1 −1,235 $2.02 $2K 11,329
2024-12-18 Pimblett Emily CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +5,000 12,564
2024-12-18 Pimblett Emily CHIEF ACCOUNTING OFFICER Option exercise · Restricted Stock Units 10b5-1 −5,000 25,000
2024-09-20 Pimblett Emily CHIEF ACCOUNTING OFFICER Sale 10b5-1 −1,182 $8.18 $10K 7,573
2024-09-20 Pimblett Emily CHIEF ACCOUNTING OFFICER Sale 10b5-1 −9 $8.06 $73 7,564
2024-09-18 Pimblett Emily CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +5,000 8,755
2024-09-18 Pimblett Emily CHIEF ACCOUNTING OFFICER Option exercise · Restricted Stock Units 10b5-1 −5,000 30,000
2024-06-20 Pimblett Emily CHIEF ACCOUNTING OFFICER Sale −1,245 $7.21 $9K 3,755
2024-06-18 Pimblett Emily CHIEF ACCOUNTING OFFICER Option exercise +5,000 5,000
2024-06-18 Pimblett Emily CHIEF ACCOUNTING OFFICER Option exercise · Restricted Stock Units −5,000 35,000
2024-03-18 Pimblett Emily CHIEF ACCOUNTING OFFICER Option exercise · Restricted Stock Units +40,000 40,000

Page 1 of 1 · 18 trades